Geode Capital Management’s Tango Therapeutics TNGX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.06M | Buy |
1,768,913
+385,476
| +28% | +$1.97M | ﹤0.01% | 2426 |
|
|
2025
Q1 | $1.9M | Sell |
1,383,437
-3,012
| -0.2% | -$4.13K | ﹤0.01% | 3055 |
|
|
2024
Q4 | $4.29M | Buy |
1,386,449
+18,187
| +1% | +$56.2K | ﹤0.01% | 2815 |
|
|
2024
Q3 | $10.5M | Buy |
1,368,262
+142,710
| +12% | +$1.1M | ﹤0.01% | 2347 |
|
|
2024
Q2 | $10.5M | Buy |
1,225,552
+92,017
| +8% | +$790K | ﹤0.01% | 2293 |
|
|
2024
Q1 | $9M | Buy |
1,133,535
+36,433
| +3% | +$289K | ﹤0.01% | 2387 |
|
|
2023
Q4 | $10.9M | Buy |
1,097,102
+62,108
| +6% | +$615K | ﹤0.01% | 2297 |
|
|
2023
Q3 | $11.7M | Buy |
1,034,994
+96,157
| +10% | +$1.08M | ﹤0.01% | 2165 |
|
|
2023
Q2 | $3.12M | Buy |
938,837
+51,966
| +6% | +$173K | ﹤0.01% | 2950 |
|
|
2023
Q1 | $3.5M | Buy |
886,871
+34,503
| +4% | +$136K | ﹤0.01% | 2790 |
|
|
2022
Q4 | $6.18M | Buy |
852,368
+12,605
| +2% | +$91.4K | ﹤0.01% | 2547 |
|
|
2022
Q3 | $3.04M | Sell |
839,763
-150,737
| -15% | -$545K | ﹤0.01% | 2935 |
|
|
2022
Q2 | $4.49M | Buy |
990,500
+397,158
| +67% | +$1.8M | ﹤0.01% | 2756 |
|
|
2022
Q1 | $4.5M | Buy |
593,342
+6,165
| +1% | +$46.7K | ﹤0.01% | 2854 |
|
|
2021
Q4 | $6.42M | Buy |
587,177
+158,542
| +37% | +$1.73M | ﹤0.01% | 2746 |
|
|
2021
Q3 | $5.54M | Buy |
428,635
+414,626
| +2,960% | +$5.36M | ﹤0.01% | 2847 |
|
|
2021
Q2 | $159K | Buy |
+14,009
| New | +$159K | ﹤0.01% | 4423 |
|